CASI
Casi Pharmaceuticals, Inc.
Application Filed: 2018-04-25
Trademark Application Details
PUBLICATION/ISSUE REVIEW COMPLETE
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87892837 |
| Registration Number | 5748674 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Stacey J. Watson |
| Attorney Docket Number | US-CALOR001C |
| Law Office Assigned | L70 |
| Employee Name | SMITH, CYNTHIA RINALDI |
Timeline
| 2014-06-16 | Date of First Use |
| 2018-04-25 | Application Filed |
| 2019-01-18 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-01-18 | Status: Live/Pending |
| 2019-02-06 | Transaction Date |
| 2019-02-26 | Published for Opposition |
| 2019-05-14 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  CASI PHARMACEUTICALS, INC. |
| Address | 9620 Medical Center Drive, Suite 300 Rockville DE 20850 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies |
| GS0421 | Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-04-28 | 1 NWAP I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2018-05-01 | 2 PARI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-05-04 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO LIE | 2018-05-06 | 4 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2018-05-09 | 5 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-16 | 6 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-08-16 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-08-16 | 8 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-08-16 | 9 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-01-16 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-01-16 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-01-16 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-01-16 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-02-06 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-02-26 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-26 | 16 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-05-14 | 17 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-05-14 | 18 REM1 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 